Saturday, October 3, 2026

EUR/CHF Went Down By Over 1% In The Last 21 Sessions

ViaNews Editorial Team

September 10, 2024

EUR/CHF Went Down By Over 1% In The Last 21 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.66% for the last 21 sessions. At 00:06 EST on Tuesday, 10 September, EUR/CHF (EURCHF) is $0.94.

EUR/CHF's yearly highs and lows, it's 3.776% up from its 52-week low and 5.629% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.10%, a negative 0.05%, and a positive 0.29%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.16% (last week), 0.26% (last month), and 0.29% (last quarter), respectively.

News about

  • Eur/usd holds ground below 1.1100, faces challenges due to rising odds of ECB rate cut. According to FXStreet on Monday, 9 September, "However, the EUR/USD pair's upside may be capped, as recent eurozone inflation data have solidified expectations of a rate cut by the European Central Bank (ECB) at upcoming Thursday's policy meeting."
  • According to FXStreet on Monday, 9 September, "Expect EUR/USD to not drift too far away from 1.1100 over the next couple of days with the US election debate perhaps the first big driver this week."
  • Eur/usd: trading a little lower – rabobank. According to FXStreet on Monday, 9 September, "As the market turns its attention to this week's events, which include the key US CPI inflation release, EUR/USD is trading a little lower. ", "Consequently, we do not see EUR/USD trading much higher than 1.12 in the coming months. "
  • Eur/usd slips as ECB rate cut expectations weigh, drops below 1.1100. According to FXStreet on Monday, 9 September, "From a technical standpoint, the EUR/USD remains neutral to upward bias, though a decisive break below the September 3 low of 1.1026 might open the door for further downside. "

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com